MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2018 International Congress

    Deep brain stimulation and its efficacy using microelectrode recording

    V. Rama Raju, R. Borgohain (Hyderabad, India)

    Objective: To render the significance of microelectrode recording and elucidate its prognostic role in response to STNDBS. Background: Studies[1]-[9] have correlated local field potential(LFP) and…
  • 2018 International Congress

    Surgery-, hardware – and chronic stimulation-related adverse events following subthalamic nucleus deep brain stimulation for Parkinson’s disease

    B. Gonenli Kocer, E. Ozturk, S. Comoglu, M. Sorar, H. Kertmen (Ankara, Turkey)

    Objective: To evaluate the adverse events (AEs) following subthalamic nucleus (STN) deep brain stimulation (DBS) for Parkinson’s disease (PD) during 6 years period. Background: The…
  • 2018 International Congress

    Impact of changes in resistance on current delivered in constant voltage DBS stimulator in Parkinson’s Disease

    S. Meka, T. Syed, S. Kumar, S. Tandra, R. Kandadai, S. Turaga, R. Borgohain (Hyderabad, India)

    Objective: To assess change in resistance and current with voltage and rate changes in Parkinson’s Disease (PD) patients on DBS therapy. Background: Currently we use…
  • 2018 International Congress

    Toe dystonia in Parkinson’s disease: Impact of subthalamic nucleus deep brain stimulation

    C. Laurencin, S. Montaut, T. Danaila, C. Vial, S. Thobois (Lyon, France)

    Objective: To analyze the prevalence and the evolution of toe dystonia in parkinson's disease (PD) patients candidate to subthalamic nucleus deep brain stimulation (STN-DBS). Background:…
  • 2018 International Congress

    Vitamin B3 and Neurodevelopment in Parkinson’s Disease

    A. Williams, S. Griffin, R. Fricker (Birmingham, United Kingdom)

    Objective: This study aimed to investigate the potential of vitamin B3 to promote the conversion of stem cells to mature central nervous system (CNS) neurons.…
  • 2018 International Congress

    Intensive speech rehabilitation in degenerative ataxias improves intelligility

    A. Vogel, N. Rommel, M. Synofzik (Melbourne, Australia)

    Objective: To test the efficacy and tolerability of intensive home based treatment for dysarthria in ataxia Background: The loss of the ability to speak is…
  • 2018 International Congress

    Genotype-phenotype correlations in 104 Uzbekish families with Spinocerebellar ataxias

    F. Rakhimov, Y. Majidova, G. Rakhimbaeva (Tashkent, Uzbekistan)

    Objective: Spinocerebellar ataxias are neurodegenerative disorders involving the cerebellum and its connections. There are more than 30 distinct subtypes, 16 of which are associated with…
  • 2018 International Congress

    Novel CACNA1A gene mutation in a Taiwan family with episodic ataxia type 2

    KF. Chen, CH. Tsai, DC. Wu (Taichung, Taiwan)

    Objective: To illustrate a family of episodic ataxia type 2 with atypical presentations and a novel mutation of CACNA1A gene Background: The episodic ataxias (EAs)…
  • 2018 International Congress

    Under three seconds: Objective speech markers of ataxia in Multiple Sclerosis

    G. Noffs, F. Boonstra, S. Kolbe, A. Evans, H. Butzkeuven, T. Perera, A. Walt, A. Vogel (Melbourne, Australia)

    Objective: To examine the relationship between objective markers of speech motor control, disease severity and ataxia. Background: Mild dysarthria is a common symptom of Multiple…
  • 2018 International Congress

    Spinocerebellar Ataxia Type 2 Presenting with Chorea: Korean Cases

    D. Yoo, J.Y. Lee, B. Jeon (Seoul, Republic of Korea)

    Objective: To report cases of SCA2 presenting with chorea, which have not been reported in Korea Background: Spinocerebellar ataxias (SCAs) manifest ethnic and geographical differences…
  • « Previous Page
  • 1
  • …
  • 65
  • 66
  • 67
  • 68
  • 69
  • …
  • 177
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Welcome to the MDS Abstracts Site
    • Effect of marijuana on Essential Tremor: A case report
    • Advanced Search
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley